Ahmed Kamal

This inventor holds 50 USPTO granted patents and 1 published patent application, plus 4 CIPO patents and 26 EPO patents, primarily in Anticancer Agents. Top assignees: Council of Scientific and Industrial Research, Other. Active years: 2002-2021.

USPTO Granted Patents = 50 (Patent Applications = 1)

% Patents Active = 52.0

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 26 (Patent Applications = 26)

Average Co-Inventor Count = 3.9

ph-index = 9

Forward Citations = 346(Granted Patents)

Forward Citations (Not Self Cited) = 338(Dec 10, 2025)

Location History:

Hyderabad 500 007, Andhra Pradesh, IN (2009)
Andhra Pradesh, IN (2002 - 2017)
Hyderabad, IN (2002 - 2021)

Company Filing History:

49 out of 2,129

Council of Scientific and Industrial Research

patents

1 out of 834,453

Other

patents

Years Active: 2002-2021

Loading Chart...

Areas of Expertise:

Anticancer Agents

Benzothiazole

Pyrrolobenzodiazepine

Anti-Tubercular

Chalcones

Conjugates

Hybrid Compounds

Synthesis

Pyrazole

Piperazine

Process Preparation

Pharmaceuticals

50 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11174230 - (E)-4-(4-acrylamidophenoxy)-N-methylpicolinamide conjugates as potential anticancer agents (2021-11-16),

2. 10947248 - 4β-amidotriazole linked podophyllotoxin derivatives as potential anticancer agents (2021-03-16),

3. 10392385 - N-((1-phenyl-9H-pyrido[3,4-b]indol-3-yl)methyl)cinnamamides as potential anticancer agents and preparation thereof (2019-08-27),

4. 10246411 - (Z)-3,4,5-trimethoxystyrylbenzenesulfonamides as potential anticancer agents (2019-04-02),

5. 9951049 - Pyrazole linked benzimidazole conjugates and a process for preparation thereof (2018-04-24),

6. 9949970 - Synthesis of new benzothiazole derivatives as potential anti-tubercular agents (2018-04-24),

7. 9878977 - N-((3,4,5-trimethoxystyryl)aryl)cinnamamide compounds as potential anticancer agents and process for the preparation thereof (2018-01-30),

8. 9783537 - 3-(4-ethylnylphenyl) pyridopyrimidinone compounds and process for preparation thereof useful as potential anticancer agents (2017-10-10),

9. 9604933 - Pyrazolochalcones as potential anticancer agents (2017-03-28),

10. 9309225 - [object Object] (2016-04-12),

11. 9273039 - Synthesis of new benzothiazole derivatives as potential anti-tubercular agents (2016-03-01),

12. 9150840 - [object Object] (2015-10-06),

13. 9108960 - Nitrofurfuryl substituted phenyl linked piperidino-oxadiazoline conjugates as anti-tubercular agents and process for the preparation thereof (2015-08-18),

14. 9085557 - Quinolylpiperazino substituted thiolactone compounds and process for the preparation thereof (2015-07-21),

15. 9029553 - 2-anilino nicotinyl linked 2-amino benzothiazole conjugates and process for the preparation thereof (2015-05-12),

Title: Unveiling the Inventive Journey of Ahmed Kamal

Introduction:

Ahmed Kamal, a prolific inventor based in Hyderabad, India, has been making waves in the field of cancer research with his groundbreaking patented inventions. With an impressive portfolio of 49 patents to his name, Kamal is a trailblazer in the realm of innovative oncology solutions.

Latest Patents:

1. "(E)-4-(4-acrylamidophenoxy)-N-methylpicolinamide conjugates as potential anticancer agents": Kamal's invention showcases a compound designed to combat human cancer cell lines, offering a new avenue in the fight against cancer.

2. "4β-amidotriazole linked podophyllotoxin derivatives as potential anticancer agents": This patent highlights the synthesis of novel derivatives to target cancer cells, emphasizing Kamal's commitment to advancing cancer treatment.

Career Highlights:

Ahmed Kamal is currently associated with the esteemed Council of Scientific & Industrial Research, where his innovative spirit and dedication have flourished. His impactful contributions have not only revolutionized cancer research but have also inspired a new generation of inventors.

Collaborations:

In his pursuit of innovation, Kamal has collaborated closely with accomplished peers such as Arutla Viswanath and Ramulu Poddutoori. Their combined efforts have led to the development of groundbreaking solutions that have the potential to transform the landscape of oncology.

Conclusion:

Ahmed Kamal's relentless pursuit of innovation and his significant contributions to the field of cancer research underscore his status as a visionary inventor. His patents stand as a testament to his ingenuity and unwavering commitment to making a positive impact on society.